{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:07:51Z","timestamp":1761919671110},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/pas.0b013e31826df00b","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T12:41:00Z","timestamp":1355229660000},"page":"147-151","source":"Crossref","is-referenced-by-count":15,"title":["A Case of Nonleukemic Myeloid Sarcoma With FIP1L1-PDGFRA Rearrangement"],"prefix":"10.1097","volume":"37","author":[{"given":"Dong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Bachanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhett P.","family":"Ketterling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kebede H.","family":"Begna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis A.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Viswanatha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-18-20210131","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/01.mph.0000193467.06938.77","article-title":"Idiopathic hypereosinophilic syndrome in children: report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement.","volume":"27","author":"Rives","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"R3-18-20210131","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.leukres.2005.11.011","article-title":"FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature.","volume":"30","author":"Pardanani","year":"2006","journal-title":"Leuk Res"},{"key":"R4-18-20210131","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"R5-18-20210131","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood-2003-05-1627","article-title":"CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy.","volume":"102","author":"Pardanani","year":"2003","journal-title":"Blood"},{"key":"R6-18-20210131","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.leu.2404662","article-title":"Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma.","volume":"21","author":"Metzgeroth","year":"2007","journal-title":"Leukemia"},{"key":"R7-18-20210131","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/leu.2010.272","article-title":"PDGFRA rearrangement leading to hyper-eosinophilia, T-lymphoblastic lymphoma, myeloproliferative neoplasm and precursor B-cell acute lymphoblastic leukemia.","volume":"25","author":"Huang","year":"2011","journal-title":"Leukemia"},{"key":"R8-18-20210131","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","article-title":"Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness.","volume":"101","author":"Klion","year":"2003","journal-title":"Blood"},{"key":"R9-18-20210131","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2003-08-2798","article-title":"Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome.","volume":"103","author":"Klion","year":"2004","journal-title":"Blood"},{"key":"R10-18-20210131","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1182\/blood-2004-03-0787","article-title":"FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia.","volume":"104","author":"Pardanani","year":"2004","journal-title":"Blood"},{"key":"R11-18-20210131","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood-2004-01-0246","article-title":"Imatinib targets other than bcrabl and their clinical relevance in myeloid disorders.","volume":"104","author":"Pardanani","year":"2004","journal-title":"Blood"},{"key":"R12-18-20210131","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1080\/10428190400002293","article-title":"Rapid reversion of Loefflers endocarditis by imatinib in early stage clonal hypereosinophilic syndrome.","volume":"45","author":"Rotoli","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"R13-18-20210131","first-page":"871","article-title":"FIP1L1-PDGFRA and c-kit D816V mutation-based clonality studies in systemic mast cell disease associated with eosinophilia.","volume":"89","author":"Tefferi","year":"2004","journal-title":"Haematologica"},{"key":"R14-18-20210131","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.leu.2403722","article-title":"Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics.","volume":"19","author":"Roche-Lestienne","year":"2005","journal-title":"Leukemia"},{"key":"R15-18-20210131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2141.2005.05698.x","article-title":"Rapid reversion of eosinophilic gastroenteritis associated with FIP1L1-PDGFRA fusion after targeted therapy with imatinib.","volume":"132","author":"Pitini","year":"2006","journal-title":"Br J Haematol"},{"key":"R16-18-20210131","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/hmg\/11.12.1391","article-title":"The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA.","volume":"11","author":"Baxter","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R17-18-20210131","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/gcc.20359","article-title":"Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion gene.","volume":"45","author":"Walz","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"R18-18-20210131","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.2007.06628.x","article-title":"Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia.","volume":"138","author":"Curtis","year":"2007","journal-title":"Br J Haematol"},{"key":"R19-18-20210131","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/sj.leu.2404154","article-title":"Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia.","volume":"20","author":"Score","year":"2006","journal-title":"Leukemia"},{"key":"R20-18-20210131","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/sj.leu.2404596","article-title":"Fusion of FIP1L1 and RARA as a result of a novel t(4;17)(q12;q21) in a case of juvenile myelomonocytic leukemia.","volume":"21","author":"Buijs","year":"2007","journal-title":"Leukemia"},{"key":"R22-18-20210131","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2362.2007.01757.x","article-title":"FIP1L1PDGFRA is a molecular marker of chronic eosinophilic leukaemia but not for systemic mastocytosis.","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"R23-18-20210131","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/sj.leu.2402958","article-title":"Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy.","volume":"17","author":"Tsimberidou","year":"2003","journal-title":"Leukemia"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0b013e31826df00b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:57:39Z","timestamp":1620968259000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201301000-00018"}},"subtitle":["An Unusual Presentation of a Rare Disease"],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e31826df00b","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}